Open access
Aug 2026
ACE2-PNA conjugates exploit viral endocytosis for targeted intracellular delivery and exhibit dual antiviral efficacy against SARS-CoV-2
A Receptor-Drug Conjugate (RDC) strategy, in which a therapeutic payload is covalently linked to a decoy receptor, enabling virus-triggered targeted intracellular delivery, and has significant implications for reducing off-target toxicity and enhancing antiviral potency.
Yi-Fei Wang, Jing-Han Xu, Yi-Quan Chen et al.
· Molecular Biomedicine · 0 citations